Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 13.278.439.274.8714.56

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 13.27 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202313.27
Mar20228.43
Mar20219.27
Mar20204.87
Mar201914.56

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 13.27
57.41
Mar2022 8.43
-9.06
Mar2021 9.27
90.35
Mar2020 4.87
-66.55
Mar2019 14.56 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹29,927.3 Cr -1.8% 10.8% 91.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

10.8%

91.6%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses